Prognostic Significance of Histopathology of Primary Conjunctival Melanoma in Caucasians

REFERENCES

• Tuomaala S, Eskelin S, Tarkkanen A, Kivelä T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002; 43: 3399–3408
   PubMed Web of Science ®Google Scholar
• Inskip P D, Devesa S S, Fraumeni J F. Trends in the incidence of ocular melanoma in the United States, 1974–1998. Cancer Causes Control. 2003; 14: 251–257
   PubMed Web of Science ®Google Scholar
• Yu G P, Hu D N, McCormick S, Finger P T. Conjunctival melanoma: is it increasing in the United States?. Am J Ophthalmol 2003; 135: 800–806
   PubMed Web of Science ®Google Scholar
• Tuomaala S, Kivelä T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 2004; 111: 816–821
   PubMed Web of Science ®Google Scholar
• de Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a clinico-pathological and follow-up study. M.D. Thesis, University of Leiden, The Netherlands, Leiden 1990
   Google Scholar
• Esmaeli B, Wang X, Youssef A, Gershenwald J E. Patterns of regional and distant metastasis in patients with conjunctival melanoma. Experience at a cancer center over four decades. Ophthalmology 2001; 108: 2101–2105
   PubMed Web of Science ®Google Scholar
• Folberg R, McLean I W, Zimmerman L E. Conjunctival melanosis and melanoma. Ophthalmology. 1984; 91: 673–678
   PubMed Web of Science ®Google Scholar
• Shields C L. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc. 2000; 98: 471–492
   PubMedGoogle Scholar
• Eskelin S, Summanen P, Pyrhönen S, Tarkkanen A, Kivelä T. Screening for metastatic uveal melanoma revisited. Cancer 1999; 85: 1151–1159
   PubMed Web of Science ®Google Scholar
• Missotten G S, Keijser S, De Keizer R J, de Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci. 2005; 46: 75–82
   PubMed Web of Science ®Google Scholar
• Silvers D N, Jakobiec F A, Freeman T R, Lefkowitch J H, Elie R C. Melanoma of the conjunctiva: a clinicopathological study. Ocular and Adnexal Tumors, F A Jakobiec. Aesculapius, Birmingham 1978; 582–599
   Google Scholar
• Lommatzsch P K, Lommatzsch R E, Kirsch I, Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol. 1990; 74: 615–619
   PubMed Web of Science ®Google Scholar
• Paridaens A DA, Minassian D C, McCartney A CE, Hungerford J L. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol. 1994; 78: 252–259
   PubMed Web of Science ®Google Scholar
• Folberg R, McLean I W, Zimmerman L E. Malignant melanoma of the conjunctiva. Hum Pathol. 1985; 16: 136–143
   PubMed Web of Science ®Google Scholar
• De Potter P, Shields C L, Shields J A, Menduke H. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol. 1993; 77: 624–630
   PubMed Web of Science ®Google Scholar
• Anastassiou G, Esser M, Bader E, Steuhl K P, Bornfeld N. Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanoma. Melanoma Res. 2004; 14: 381–385
   PubMed Web of Science ®Google Scholar
• Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl K P. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol. 2002; 86: 163–167
   PubMed Web of Science ®Google Scholar
• Bobic-Radovanovic A, Latkovic Z, Marinkovic J, Radovanovic Z. Predictors of survival in malignant melanoma of the conjunctiva: a clinico-pathological and follow-up study. Eur J Ophthalmol. 1998; 8: 4–7
   PubMed Web of Science ®Google Scholar
• Seregard S, Oskarsson M, Spångberg B. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma. Invest Ophthalmol Vis Sci. 1996; 37: 1451–1458
   PubMed Web of Science ®Google Scholar
• Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969–91. Acta Ophthalmol (Copenh). 1992; 70: 289–296
   PubMed Web of Science ®Google Scholar
• Jeffrey I J, Lucas D R, McEwan C, Lee W R. Malignant melanoma of the conjunctiva. Histopathology. 1986; 10: 363–378
   PubMed Web of Science ®Google Scholar
• Werschnik C, Lommatzsch P K. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol. 2002; 25: 248–255
   PubMed Web of Science ®Google Scholar
• Shields C L, Shields J A, Gunduz K, Cater J, Mercado G V, Gross N, Lally B. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000; 118: 1497–1507
   PubMedGoogle Scholar
• Seregard S, Spångberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998; 105: 485–91
   PubMed Web of Science ®Google Scholar
• Moshari A, McLean I W. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections. Invest Ophthalmol Vis Sci. 2001; 42: 1160–1163
   PubMed Web of Science ®Google Scholar
• Al Jamal R T, Mäkitie T, Kivelä T. Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body. Invest Ophthalmol Vis Sci 2003; 44: 2381–2389
   PubMed Web of Science ®Google Scholar
• McLean I W, Keefe K S, Burnier M N. Uveal melanoma: comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology. 1997; 104: 777–780
   PubMed Web of Science ®Google Scholar
• Sørensen F B, Gamel J W, Jensen O A, Ladekarl M, McCurdy J. Prognostic value of nucleolar size and size pleomorphism in choroidal melanomas. APMIS. 1993; 101: 358–368
   PubMed Web of Science ®Google Scholar
• Gamel J W, McCurdy J B, McLean I W. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci. 1992; 33: 1919–1922
   PubMed Web of Science ®Google Scholar
• Huntington A, Haugan P, Gamel J, McLean I. A simple cytologic method for predicting the malignant potential of intraocular melanoma. Pathol Res Practice. 1989; 185: 631–634
   PubMed Web of Science ®Google Scholar
• Folberg R, Rummelt V, Parys-van Ginderdeuren R, Hwang T, Woolson R F, Pe'er J, Gruman L M. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993; 100: 1389–1398
   PubMed Web of Science ®Google Scholar
• Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst 1999; 91: 359–367
   PubMedGoogle Scholar
• Foss A JE, Alexander R A, Hungerford J L, Harris A L, Cree I A, Lightman S. Reassessment of the PAS patterns in uveal melanoma. Br J Ophthalmol. 1997; 81: 240–246
   PubMed Web of Science ®Google Scholar
• Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 1999; 40: 2471–480
   PubMed Web of Science ®Google Scholar
• Foss A JE, Alexander R A, Jefferies L W, Hungerford J L, Harris A L, Lightman S. Microvessel count predicts survival in uveal melanoma. Cancer Res. 1996; 56: 2900–2903
   PubMed Web of Science ®Google Scholar
• Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001; 42: 1414–1421
   PubMed Web of Science ®Google Scholar
• Toivonen P, Mäkitie T, Kujala E, Kivelä T. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci. 2004; 45: 1–6
   PubMed Web of Science ®Google Scholar
• Tuomaala S, Aine E, Saari K M, Kivelä T. Corneally displaced malignant conjunctival melanomas. Ophthalmology 2002; 109: 914–919
   PubMed Web of Science ®Google Scholar
• Folberg R, Pe'er J, Gruman L M, Woolson R F, Jeng G, Montague P R, Moninger T O, Yi H, Moore K C. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992; 23: 1298–1305
   PubMed Web of Science ®Google Scholar
• Ramani P, Bradley N J, Fletcher C DM. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology. 1990; 17: 237–242
   PubMed Web of Science ®Google Scholar
• Parmar M KB, Machin D. Survival Analysis. A Practical Approach. John Wiley & Sons, Chichester, NY 1995
   Google Scholar
• Hosmer D W, Jr., Lemeshow S. Applied Survival Analysis. Regression Modeling of Time to Event Data. John Wiley & Sons, New York 1999
   Google Scholar
• Cleves M. Analysis of multiple failure-time data with Stata. Stata Technical Bulletin 1999
   Google Scholar
• Therneau T M, Grambsch P M. Modeling Survival Data: Extending the Cox Model. Springer, New York 2000
   Google Scholar
• Callender G R. Malignant melanocytic tumors of the eye. A study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol. 1931; 36: 131–140
   Google Scholar
• McLean I W, Foster W D, Zimmerman L E. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol. 1982; 13: 123–132
   PubMed Web of Science ®Google Scholar
• Seddon J M, Albert D M, Lavin P T, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983; 101: 1894–1899
   PubMed Web of Science ®Google Scholar
• Liu W, Dowling J P, Murray W K, McArthur G A. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006; 142: 1551–1558
   PubMed Web of Science ®Google Scholar
• Paridaens A D, Seregard S, Minassian D, Hungerford J L, McCartney A C. AgNOR counts in conjunctival malignant melanoma lack prognostic value. Br J Ophthalmol. 1992; 76: 621–623
   PubMed Web of Science ®Google Scholar
• Clark W H, Elder D E, Guerry D P. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 1893–1904
   PubMedGoogle Scholar
• Clemente C G, Mihm M C, Bufalino R, Zurrida S, Collini P. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77: 1303–1310
   PubMed Web of Science ®Google Scholar
• Crawford J B. Conjunctival melanomas: prognostic factors a review and an analysis of a series. Trans Am Ophthalmol Soc. 1980; 78: 467–502
   PubMedGoogle Scholar
• Piras F, Colombrari R, Minerba L, Murtas D, Floris C, Maxia C, Corbu A, Perra M T, Sirigu P. The predictive value of CD8, CD4, CD68 and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer. 2005; 104: 1248–1254
   Web of Science ®Google Scholar
• de l a, Cruz P OJ, Specht C S, McLean I W. Lymphocytic infiltration in uveal malignant melanoma. Cancer. 1990; 65: 112–115
   PubMed Web of Science ®Google Scholar
• Whelchel J C, Farah S E, McLean I W, Burnier M N. Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma. Invest Ophthalmol Vis Sci. 1993; 34: 2603–2606
   PubMed Web of Science ®Google Scholar
• Chen X, Maniotis A J, Majumdar D, Pe'er J, Folberg R. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci. 2002; 43: 2533–2539
   PubMed Web of Science ®Google Scholar
• Scholes A G, Damato B E, Nunn J, Hiscott P, Grierson I, Field J K. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 2003; 44: 1008–1011
   PubMed Web of Science ®Google Scholar